The current account surplus for fiscal year 2022 has shrunk to less than half of the previous year.
The deficit in goods trade has reached a record high, and payments for overseas IT services used by companies and individuals continue to increase.
The power to earn through goods is weakening, and the weakness of next-generation industries that can earn foreign currency has become apparent.
Due to an increase in the import of COVID-19 therapeutic drugs, the balance of payments for pharmaceuticals has expanded its deficit to 4.3 trillion yen.
2022年度の経常収支は前年度から半分以下に縮小している。
モノの貿易に絡む赤字が過去最大に膨らみ、企業や個人が使う海外ITサービスへの支払い増も止まらない。
モノで稼ぐ力は鈍り、外貨を獲得できる次世代産業の弱さが浮き彫りになった。
新型コロナウイルス治療薬の輸入増などを受け、医薬品の収支も4.3兆円の赤字と赤字幅を広げる。
Word Exercise
英単語
日本語
例文
surplus
黒字
The current account surplus for fiscal year 2022 has shrunk to less than half of the previous year.
deficit
赤字
The deficit in goods trade has reached a record high, and payments for overseas IT services used by companies and individuals continue to increase.
goods
商品
The power to earn through goods is weakening, and the weakness of next-generation industries that can earn foreign currency has become apparent.
next-generation
次世代
The power to earn through goods is weakening, and the weakness of next-generation industries that can earn foreign currency has become apparent.
overseas
海外の
The deficit in goods trade has reached a record high, and payments for overseas IT services used by companies and individuals continue to increase.
services
サービス
The deficit in goods trade has reached a record high, and payments for overseas IT services used by companies and individuals continue to increase.
increase
増加する
The deficit in goods trade has reached a record high, and payments for overseas IT services used by companies and individuals continue to increase.
import
輸入する
Due to an increase in the import of COVID-19 therapeutic drugs, the balance of payments for pharmaceuticals has expanded its deficit to 4.3 trillion yen.
therapeutic
治療の
Due to an increase in the import of COVID-19 therapeutic drugs, the balance of payments for pharmaceuticals has expanded its deficit to 4.3 trillion yen.
pharmaceuticals
医薬品
Due to an increase in the import of COVID-19 therapeutic drugs, the balance of payments for pharmaceuticals has expanded its deficit to 4.3 trillion yen.
